B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TRPA1

MOLECULAR TARGET

transient receptor potential cation channel, subfamily A, member 1

UniProt: Q6RI86NCBI Gene: 31289623 compounds

TRPA1 (transient receptor potential cation channel, subfamily A, member 1) is targeted by 23 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TRPA1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1acrolein1.795
2Resveratrol1.614
3juglone hydroxylase [Supplementary Concept] catalyzes1.614
4Nicotine Nicotine is highly toxic alkaloid. It is1.614
5cbd1.393
6plumbagin [Supplementary Concept]1.393
7cannabidiol1.393
8Pyruvaldehyde1.393
9cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester [Supplementary Concept]1.393
10pterostilbene1.102
11Acetaldehyde1.102
12Formaldehyde1.102
13Iodoacetamide1.102
14Masoprocol1.102
15Dehydroepiandrosterone Sulfate0.691
16auraptene0.691
17Camphor0.691
18diallyl trisulfide0.691
19Disulfiram0.691
20Gentamicins0.691
21Niflumic Acid0.691
22Nitrendipine0.691
23Probenecid0.691

About TRPA1 as a Drug Target

TRPA1 (transient receptor potential cation channel, subfamily A, member 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 23 compounds with documented TRPA1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TRPA1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.